Table 2.
Baseline subject demographics:
Formulation A N=8* |
Formulation B N=8 |
Formulation C N=8 |
Total N=24 |
|
---|---|---|---|---|
Gender, M/F | 3/5 | 3/5 | 1/7 | 7/17 |
Age (years) | ||||
Median | 48.5 | 52 | 50.5 | 51 |
Range | 36–66 | 27–77 | 42–65 | 27–77 |
Race | ||||
Caucasian | 8 | 8 | 8 | 24 |
Non-Caucasian | 0 | 0 | 0 | 0 |
Type of MS | ||||
Relapsing-remitting | 4 | 3 | 5 | 12 |
Primary progressive | 1 | 0 | 0 | 1 |
Secondary progressive | 3 | 5 | 3 | 11 |
MS duration median (range in yrs) | 11.5 (1–16) | 21 (8–33) | 11.5 (2–35) | 12.5 (1–35) |
EDSS median (range) | 4.0 (2.0–7.0) | 5.0 (2.5–7.5) | 4.0 (2.0–8.0) | 4.0 (2.0–8.0) |
N denotes the number of subjects in each treatment group.